Page last updated: 2024-09-04

ro 136680 and 2-pyrrolidone

ro 136680 has been researched along with 2-pyrrolidone in 1 studies

Compound Research Comparison

Studies (ro 136680)	Trials (ro 136680)	Recent Studies (post-2010) (ro 136680)	Studies (2-pyrrolidone)	Trials (2-pyrrolidone)	Recent Studies (post-2010) (2-pyrrolidone)
5	0	1	134	1	60

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nakamura, K; Shirane, M	1

Other Studies

1 other study(ies) available for ro 136680 and 2-pyrrolidone

Article	Year
Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP. Brain research, 2001, Oct-19, Volume: 916, Issue:1-2 Topics: Acetylcholine; Animals; Anisoles; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Glutamic Acid; Hydroxybenzoate Ethers; Hydroxybenzoates; Male; Mecamylamine; Microdialysis; Nicotinic Antagonists; Nootropic Agents; Prefrontal Cortex; Presynaptic Terminals; Pyrrolidinones; Raphe Nuclei; Rats; Rats, Inbred SHR; Receptors, Cholinergic; Receptors, Glutamate; Serotonin; Ventral Tegmental Area	2001

Article

Year

Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP.

Brain research, 2001, Oct-19, Volume: 916, Issue:1-2

Topics: Acetylcholine; Animals; Anisoles; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Glutamic Acid; Hydroxybenzoate Ethers; Hydroxybenzoates; Male; Mecamylamine; Microdialysis; Nicotinic Antagonists; Nootropic Agents; Prefrontal Cortex; Presynaptic Terminals; Pyrrolidinones; Raphe Nuclei; Rats; Rats, Inbred SHR; Receptors, Cholinergic; Receptors, Glutamate; Serotonin; Ventral Tegmental Area

2001